SCOPUS 정보 검색 플랫폼

Journal of Clinical Oncology

Volumn 8, Issue 7, 1990, Pages 1263-1268

Hypersensitivity reactions from taxol

(1) Weiss, Raymond B a

a WALTER REED ARMY MEDICAL CENTER (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PACLITAXEL;

AGE; ARTICLE; CANCER CHEMOTHERAPY; FEMALE; HUMAN; HYPERSENSITIVITY REACTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; AGED; ALKALOIDS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CIMETIDINE; COLONIC NEOPLASMS; DEXAMETHASONE; DRUG ADMINISTRATION SCHEDULE; DRUG HYPERSENSITIVITY; FEMALE; HUMAN; HYPERSENSITIVITY, IMMEDIATE; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; MELANOMA; MIDDLE AGE; PACLITAXEL; PREMEDICATION;

EID: 0025326680 PISSN: 0732183X EISSN: None Source Type: Journal
DOI: 10.1200/JCO.1990.8.7.1263 Document Type: Article

Times cited : (1118)

References (12)

1
- 0019365298
- Hypersensitivity reactions to cancer chemotherapeutic agents
- Weiss RB, Bruno S: Hypersensitivity reactions to cancer chemotherapeutic agents. Ann Intern Med 94:66-72, 1981
- (1981) Ann Intern Med , vol.94 , pp. 66-72
- Weiss, R.B.¹ Bruno, S.²

2
- 0023462509
- Hypersensitivity reactions from antineoplastic agents
- Weiss RB, Baker JR: Hypersensitivity reactions from antineoplastic agents. Cancer Metas Rev 6:413-432, 1987
- (1987) Cancer Metas Rev , vol.6 , pp. 413-432
- Weiss, R.B.¹ Baker, J.R.²

3
- 0018387446
- Promotion of microtubule assembly in vitro by taxol
- Schiff PB, Fant J, Horwitz SB: Promotion of microtubule assembly in vitro by taxol. Nature 227:665-667, 1973
- (1973) Nature , vol.227 , pp. 665-667
- Schiff, P.B.¹ Fant, J.² Horwitz, S.B.³

4
- 0023595221
- Phase I trial of taxol given as a 24-hour infusion every 21 days: Responses observed in metastatic melanoma
- Wiernik PH, Schwartz EL, Einzig A, et al: Phase I trial of taxol given as a 24-hour infusion every 21 days: Responses observed in metastatic melanoma. J Clin Oncol 5:1232-1239, 1987
- (1987) J Clin Oncol , vol.5 , pp. 1232-1239
- Wiernik, P.H.¹ Schwartz, E.L.² Einzig, A.³

5
- 0024327106
- Taxol: A unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasms
- McGuire WP, Rowinsky EK, Rosenshein NB; et al: Taxol: A unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasms. Ann Intern Med 111:273-279, 1989
- (1989) Ann Intern Med , vol.111 , pp. 273-279
- McGuire, W.P.¹ Rowinsky, E.K.² Rosenshein, N.B.³

6
- 0022575675
- Phase I trial of taxol given as a 3-hour infusion every 21 days
- Kris MG, O'Connell JP, Gralla RJ, et al: Phase I trial of taxol given as a 3-hour infusion every 21 days. Cancer Treat Rep 70:605-607, 1986
- (1986) Cancer Treat Rep , vol.70 , pp. 605-607
- Kris, M.G.¹ O'Connell, J.P.² Gralla, R.J.³

7
- 0023261546
- Phase I clinical and pharmacokinetic study of taxol
- Wiernik PH, Schwartz EL, Strauman JJ, et al: Phase I clinical and pharmacokinetic study of taxol. Cancer Res 47:2486-2493, 1987
- (1987) Cancer Res , vol.47 , pp. 2486-2493
- Wiernik, P.H.¹ Schwartz, E.L.² Strauman, J.J.³

8
- 0023461334
- Phase I trial of taxol in patients with advanced cancer
- Donehower RC, Rowinsky EK, Grochow LB, et al: Phase I trial of taxol in patients with advanced cancer. Cancer Treat Rep 71:1171-1177, 1987
- (1987) Cancer Treat Rep , vol.71 , pp. 1171-1177
- Donehower, R.C.¹ Rowinsky, E.K.² Grochow, L.B.³

9
- 0023477883
- Phase I study of taxol administered as a short IV infusion daily for 5 days
- Grem JL, Tutsch KD, Simon KJ, et al: Phase I study of taxol administered as a short IV infusion daily for 5 days. Cancer Treat Rep 71:1179-1184, 1987
- (1987) Cancer Treat Rep , vol.71 , pp. 1179-1184
- Grem, J.L.¹ Tutsch, K.D.² Simon, K.J.³

10
- 0008641202
- A phase I/pharmacokinetic study of taxol given by a prolonged infusion without premedication
- abstr
- Koeller J, Brown T, Havlin K, et al: A phase I/pharmacokinetic study of taxol given by a prolonged infusion without premedication. Proc Am Soc Clin Oncol 8:82, 1989 (abstr)
- (1989) Proc Am Soc Clin Oncol , vol.8 , pp. 82
- Koeller, J.¹ Brown, T.² Havlin, K.³

11
- 0019655533
- Complement as a mediator of inflammation
- Fearon DG: Complement as a mediator of inflammation. Clin Immunol Allergy 1:225-242, 1981
- (1981) Clin Immunol Allergy , vol.1 , pp. 225-242
- Fearon, D.G.¹

12
- 0018885763
- Suspected anaphylactic reaction to Cremophor EL
- Dye D, Watkins J: Suspected anaphylactic reaction to Cremophor EL. Br Med J 280:1353, 1980
- (1980) Br Med J , vol.280 , pp. 1353
- Dye, D.¹ Watkins, J.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.